scholarly article | Q13442814 |
P50 | author | Laura Andreoli | Q61806166 |
Munther A. Khamashta | Q73418907 | ||
Maria Josè Cuadrado | Q89547142 | ||
Savino Sciascia | Q89547145 | ||
P2093 | author name string | Doruk Erkan | |
Maria Laura Bertolaccini | |||
Giovanni Sanna | |||
APS Action | |||
P2860 | cites work | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 |
Cerebral infarction associated with lupus anticoagulants--preliminary report | Q33478161 | ||
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
Diagnostic testing for coagulopathies in patients with ischemic stroke | Q34099965 | ||
Risk factors for ischemic stroke and transient ischemic attack in patients under age 50 | Q34472618 | ||
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature | Q34977289 | ||
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome | Q35158386 | ||
Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus | Q35417804 | ||
Ischaemic stroke in young adults: predictors of outcome and recurrence | Q35485985 | ||
Young strokes in Sri Lanka: an unsolved problem | Q36570388 | ||
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature | Q38122121 | ||
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome | Q39934417 | ||
Use of methodological standards in diagnostic test research. Getting better but still not good. | Q40461184 | ||
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program | Q40693493 | ||
Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events | Q40835330 | ||
Risk factors for thrombophilia in young adults presenting with thrombosis | Q43235975 | ||
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. | Q43626449 | ||
Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke? | Q43717978 | ||
Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients | Q43933330 | ||
Antiphospholipid antibodies and stroke in young women | Q44168396 | ||
Antiphospholipid antibodies in young Indian patients with stroke | Q44395700 | ||
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled study | Q46061041 | ||
Causes of ischemic stroke in young adults in Thailand: a pilot study. | Q46548942 | ||
Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adults | Q48114647 | ||
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause | Q48398617 | ||
Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population? | Q48437611 | ||
Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia | Q48537242 | ||
Anticardiolipin antibodies in ischemic stroke in the young: Indian experience | Q48630330 | ||
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. | Q50619255 | ||
Patent foramen ovale and prothrombotic markers in young stroke patients. | Q51739841 | ||
Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. | Q52342334 | ||
Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. | Q52913630 | ||
Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. | Q54475683 | ||
Antiphospholipid syndrome | Q55891386 | ||
Lupus anticoagulant and the fibrinolytic system in young patients with stroke | Q58421453 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systematic review | Q1504425 |
P304 | page(s) | 2028-2033 | |
P577 | publication date | 2014-06-18 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review | |
P478 | volume | 74 |
Q90446471 | A challenging case of neuropsychiatric systematic lupus erythematosus with recurrent antiphospholipid- related stroke: A case report and literature review |
Q48020789 | Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies |
Q27007774 | AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update |
Q34171339 | Antigen-specific immune reactions to ischemic stroke. |
Q57490088 | Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I |
Q59808719 | Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy |
Q64046338 | Antiphospholipid syndrome |
Q91390119 | Antiphospholipid syndrome - an update |
Q38410376 | Antiphospholipid syndrome: an update |
Q90415557 | Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management |
Q47998109 | Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances |
Q90706672 | IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients |
Q50041259 | Immunological Rare Diseases |
Q64043321 | Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology |
Q90521167 | MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS) |
Q51251394 | Neuropsychiatric Lupus in clinical practice. |
Q60920514 | Posterior Reversible Encephalopathy Syndrome with Stroke in Puerperal Woman with High Titer of Anti-Phospholipid IgM Antibody |
Q54266701 | Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study. |
Q64088190 | Recurrent Stroke Due to Antiphospholipid Syndrome Remitted by Immunotherapy, Not by Anticoagulation Therapy: A Case Report and Literature Review |
Q47311457 | Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition |
Q38844621 | Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment |
Q42646992 | Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity |
Q48509173 | The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome |
Q38374306 | The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome |
Q45873735 | The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study |
Q88930539 | Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment |
Q26739950 | Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay |
Search more.